anakinra,bms-986354,tocilizumab
sobi,roche,bms
['mmsm', 'tocilizumab', 'toci', 'bms-986354', 'ascertain', 'anakinra', 'bms']
bms-986354 car-t
response rates and safety promising. longer follow-up and larger sample sizes needed to ascertain durability of response. should it enter market and have reduced manufacturing time, will be a step forward #mmsm
#ash22 
Cancer doctor at @huntsmancancer with interest in myeloma, supportive care, end of life, cost-effective/evidence-based care and med-ed. No COI. Views own.